FeedworthyAI
Back to feed
GEN – Genetic Engineering and Biotechnology Newsnews

StockWatch: Axiom CEO Explains Plans for Hong Kong IPO

Monday, July 27, 2026Alex PhilippidisView original

Axiom says the special administrative region of China possesses deep biotechnology expertise, a strong appetite for clinical-stage innovation, and direct proximity to the Asian partners and capital advancing the company’s science.

The post StockWatch: Axiom CEO Explains Plans for Hong Kong IPO appeared first on GEN - Genetic Engineering and Biotechnology News.